A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Healthy Japanese Adolescents Aged 11 Years to <13 Years

Clinical trial NCT07596173 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07596173
Sponsor: GlaxoSmithKline
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria-Tetanus-acellular Pertussis Vaccines

Start date: 2026-06-29
Primary completion: 2026-09-16
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.